文献速递主动脉疾病内脏/肾动脉与血管畸形

血管内淋巴瘤相较于其他需血管重建的腹腔内恶性肿瘤的侵袭性表型

Aggressive Phenotype of Intravascular Lymphoma Relative to Other Malignant Intraabdominal Tumors Requiring Vascular Reconstruction.
PubMed 文献 · Ann Vasc Surg · 2018-09-27

单中心回顾性研究纳入了2010至2016年因腹腔或腹膜后肿瘤累及腹主动脉、腔静脉或髂动脉而接受血管移植物重建的12例成人患者,其中平滑肌肉瘤7例、生殖细胞肿瘤3例、血管内淋巴瘤2例。血管内淋巴瘤患者于主动脉重建时偶然发现,均在14个月内出现吻合口或瘤栓性假性动脉瘤,复发率100%、死亡率100%。作者认为经仔细选择的肉瘤和生殖细胞肿瘤患者可安全切除并同期行大血管重建。

要点

  • 12例腹部或腹膜后肿瘤累及大血管并重建,含平滑肌肉瘤7例、生殖细胞肿瘤3例、血管内淋巴瘤2例。
  • 血管内淋巴瘤均在主动脉重建时偶然发现,2例均在14个月内出现吻合口或瘤栓性假性动脉瘤。
  • 血管内淋巴瘤复发率100%、死亡率100%,肉瘤复发28.6%、生殖细胞肿瘤复发33.3%。

核心结论

  • 本单中心回顾提示,经仔细选择的肉瘤和生殖细胞肿瘤患者可安全切除并同期行大血管重建。
  • 相比之下,主动脉重建时偶然发现的血管内淋巴瘤病程更恶性,出现吻合口或自身血管假性动脉瘤、肿瘤复发和100%死亡率。

研究设计与样本

  • 单中心回顾性研究,纳入2010至2016年在密歇根大学因腹腔或腹膜后肿瘤累及腹主动脉、腔静脉或髂动脉而接受血管移植物重建的成人患者,共12例。

主要发现

  • 肿瘤病理包括平滑肌肉瘤7例、生殖细胞肿瘤3例、血管内淋巴瘤2例。
  • 手术方式包括腔静脉移植6例、主动脉移植3例、髂动脉移植4例、主动脉和腔静脉同时移植1例。
  • 血管内淋巴瘤患者在腹主动脉瘤治疗中或主动脉来源血栓栓塞的病理分析时被偶然发现,其他患者为计划性切除。
  • 随访9至86个月(中位数28.9),无移植物闭塞。
  • 肿瘤转移或复发见于肉瘤2例(28.6%)、生殖细胞肿瘤1例(33.3%)、血管内淋巴瘤2例(100%);2例淋巴瘤患者均在血管重建后14个月内出现多个吻合口或瘤栓性假性动脉瘤,且均在随访期间死亡。

临床怎么用

  • 作者认为,经仔细选择的肉瘤和生殖细胞肿瘤患者可安全切除并同期行大血管重建。
  • 作者建议,围手术期应由病理学家仔细审查动脉瘤内容物和栓子。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Safe resection of intraabdominal and retroperitoneal malignancies with a goal of negative margins may require vascular surgical assistance with grafting of the aorta and/or vena cava. The current report reviews malignancies associated with major vascular reconstructions at a single tertiary referral center. METHODS: Adults with abdominal or retroperitoneal tumors involving the aorta, vena cava, or iliac arteries that underwent reconstruction with vascular grafts at the University of Michigan from 2010 to 2016 were reviewed retrospectively. The initial presentation, surgical management, and outcomes were analyzed. RESULTS: Twelve patients with tumors involving the abdominal aorta, vena cava, or iliac arteries underwent major vascular reconstruction in this seven-year study period. Tumor pathology included solid tumors (leiomyosarcoma [n = 7], germ cell tumor [n = 3], and intravascular lymphoma [n = 2]). Surgical treatment included grafting of the vena cava (n = 6), aorta (n = 3), iliac artery (n = 4), or both the aorta and vena cava (n = 1). Patients with intravascular lymphoma were identified incidentally during treatment of abdominal aortic aneurysm or on pathological analysis of thromboembolism from an aortic source. Other patients had planned resection. Follow-up ranged from 9 to 86 months (median: 28.9). There were no graft occlusions. Tumor metastasized or recurred in patients with sarcoma (n = 2; 28.6%), germ cell tumor (n = 1; 33.3%), and intravascular lymphoma (n = 2; 100%). Both patients with lymphoma had multiple anastomotic or tumor-embolic pseudoaneurysms for <14 months after vascular reconstruction. Both lymphoma patients died during follow-up. CONCLUSIONS: This single-center review suggests that sarcoma and germ cell tumors may be safely resected in conjunction with major vascular reconstruction in carefully selected patients. In comparison, intravascular lymphoma identified incidentally at the time of aortic reconstruction resulted in a more malignant course with pseudoaneurysm formation of anastomoses or native vessels, cancer recurrence, and 100% mortality. Aneurysm contents and emboli should be carefully reviewed perioperatively by pathologists.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Obi AT, Kim GY, Coleman DM, et al. Aggressive Phenotype of Intravascular Lymphoma Relative to Other Malignant Intraabdominal Tumors Requiring Vascular Reconstruction. Ann Vasc Surg. 2018. PMID: 30267915. doi:10.1016/j.avsg.2018.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。